<?xml version="1.0" encoding="UTF-8"?>
<p id="para0008">An echinocandin was commenced for ten patients, as per local guidelines, pending susceptibility testing. One patient died prior to blood culture positivity and treatment. Four out of ten (40%) patients were switched to fluconazole to complete treatment. In line with recommended practice (
 <xref rid="bib0003" ref-type="bibr">3</xref>) six out of eleven patients (54.5%) had repeat blood cultures within 48 hours of treatment, eight (72.7%) patients had an echocardiogram, but only one (9.1%) had fundoscopy. Serum (
 <xref rid="bib0001" ref-type="bibr">1</xref>, 
 <xref rid="bib0002" ref-type="bibr">2</xref>, 
 <xref rid="bib0003" ref-type="bibr">3</xref>)-Î²-D-glucan(BDG) testing was performed in 54.4% (6/11) of patients; three were positive(see 
 <xref rid="tbl0001" ref-type="table">Table 1</xref>).
</p>
